Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-24

FDA Approved: MESALAMINE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mesalamine from ANI Pharmaceuticals, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)